Europe · Markets & Finance · Boursorama

Des résultats positifs de phase 2 pour le Tilrekimig de Pfizer

Published by Boursorama · France 1 d ago

Le géant pharmaceutique américain a présenté les résultats détaillés d'une étude clinique de phase 2 en cours évaluant le Tilrekimig chez des adultes atteints de dermatite…

Read the full article on Boursorama Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.boursorama.com)

Also worth reading

Financial Times

Des résultats positifs de phase 2 pour le Tilrekimig de Pfizer

Share

Also worth reading

US economy adds just 29,000 jobs in September as hiring slows sharply

G7 agrees to release diesel reserves after crisis meeting

Best cash Isa savings rates: Easy access and fixed deals in our tables

Carney plans to visit Turkey this month, sources say

US payrolls miss at 29K and the Dollar Index drops below 102.00

‘The state pension triple lock is unsustainable – changing the mechanism is overdue’